Fallbericht
Uveitis Induced by Brentuximab Vedotin-A Novel Adverse Response to Antibody-Drug Conjugate Therapy
Systemic Treatment for Patients with HER2-Positive Breast Cancer and Brain Metastases
A Hereditary Breast and Ovarian Cancer (HBOC) Patient with Metastatic Breast Cancer Lacking BRCA Loss of Heterozygosity (LOH) but Responding to PARP Inhibitor Therapy
Metastatic Choriocarcinoma after Full Term Pregnancy